Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

FDA Staff Raises Concerns on Two Cancer Drug Applications

FDA Staff Raises Concerns on Two Cancer Drug Applications
ShareXFacebook

(MedPage Today) -- For the first time since last July the FDA's Oncologic Drugs Advisory Committee (ODAC) will meet on Thursday to evaluate two cancer drugs after FDA staff voiced concerns about benefit-risk assessments, despite positive trial...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement